Published in Nutr Cancer on January 01, 2002
Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol (2015) 2.11
Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2011) 1.57
Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ (2012) 1.55
Dietary macronutrients and food consumption as determinants of long-term weight change in adult populations: a systematic literature review. Food Nutr Res (2012) 1.49
Fruits, vegetables and coronary heart disease. Nat Rev Cardiol (2009) 1.47
Increased fruit and vegetable intake has no discernible effect on weight loss: a systematic review and meta-analysis. Am J Clin Nutr (2014) 1.12
Portion size can be used strategically to increase vegetable consumption in adults. Am J Clin Nutr (2010) 1.09
Patterns and correlates of multiple risk behaviors in overweight women. Prev Med (2007) 1.08
Design of a Mediterranean exchange list diet implemented by telephone counseling. J Am Diet Assoc (2008) 0.89
A Diet and Exercise Intervention during Chemotherapy for Breast Cancer. Open Obes J (2011) 0.89
The impact of a long-term reduction in dietary energy density on body weight within a randomized diet trial. Nutr Cancer (2008) 0.89
Effects of fruit and vegetable, consumed in solid vs beverage forms, on acute and chronic appetitive responses in lean and obese adults. Int J Obes (Lond) (2012) 0.87
Development of exchange lists for Mediterranean and Healthy Eating diets: implementation in an intervention trial. J Hum Nutr Diet (2013) 0.83
A randomized feasibility trial of brief telephone counseling to increase fruit and vegetable intakes. Prev Med (2010) 0.81
Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review. Springerplus (2013) 0.76
GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol (2003) 22.63
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93
Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol (2006) 3.79
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell (2004) 3.72
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping. Cancer Res (2003) 3.52
Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res (2003) 3.42
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther (2006) 2.55
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol (2003) 2.52
Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res (2005) 2.21
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Perspectives for cancer prevention with natural compounds. J Clin Oncol (2009) 1.99
Cancer prevention with natural compounds. Semin Oncol (2010) 1.98
Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75
Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat (2005) 1.74
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer (2002) 1.62
Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst (2013) 1.60
Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril (2003) 1.58
An educational video to increase clinical trials enrollment among lung cancer patients. J Thorac Oncol (2008) 1.58
Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr (2013) 1.58
Nutrition research to affect food and a healthy life span. Am J Clin Nutr (2013) 1.57
Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr (2009) 1.56
Antioxidant effect of zinc in humans. Free Radic Biol Med (2004) 1.56
Prenatal cocaine: quantity of exposure and gender moderation. J Dev Behav Pediatr (2004) 1.55
Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res (2003) 1.51
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev (2008) 1.50
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res (2011) 1.48
Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer (2004) 1.46
Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Mol Cancer Ther (2005) 1.44
CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol (2007) 1.44
Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial. Menopause (2013) 1.42
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells. Mol Cancer Ther (2007) 1.42
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports? Cancer Epidemiol Biomarkers Prev (2009) 1.41
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res (2010) 1.40
Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis (2012) 1.38
A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev (2010) 1.34
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retention. Eur J Nucl Med Mol Imaging (2005) 1.34
Violence exposure, trauma, and IQ and/or reading deficits among urban children. Arch Pediatr Adolesc Med (2002) 1.33
Gender and alcohol moderate prenatal cocaine effects on teacher-report of child behavior. Neurotoxicol Teratol (2004) 1.33
Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol (2012) 1.33
Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther (2004) 1.30
Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol (2007) 1.30
Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer (2006) 1.29
Predictors of enrollment in lung cancer clinical trials. Cancer (2006) 1.26
An overview of the health effects of isoflavones with an emphasis on prostate cancer risk and prostate-specific antigen levels. J AOAC Int (2006) 1.24
Soy isoflavones in the treatment of prostate cancer. Nutr Cancer (2003) 1.24
Blood lead levels and specific attention effects in young children. Neurotoxicol Teratol (2007) 1.24
Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol (2012) 1.24
CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy. J Urol (2004) 1.23
Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic Biol Med (2011) 1.23
Hormone replacement therapy regimens and breast cancer risk(1). Obstet Gynecol (2002) 1.20
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology (2006) 1.19
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res (2010) 1.19
Childbearing and survival after breast carcinoma in young women. Cancer (2003) 1.18
Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol (2008) 1.17
Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control (2012) 1.17
Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sci (2010) 1.17
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma. Cancer Res (2009) 1.16
Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. BMC Cancer (2007) 1.16
Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control (2011) 1.15
Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol (2004) 1.15
Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas (2004) 1.14
Breast cancer risk and ovariectomy, hysterectomy, and tubal sterilization in the women's contraceptive and reproductive experiences study. Am J Epidemiol (2010) 1.14
Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years. Cancer Epidemiol Biomarkers Prev (2003) 1.13
Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET. J Nucl Med (2007) 1.12
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer. Invest New Drugs (2005) 1.11
An educational video to increase clinical trials enrollment among breast cancer patients. Breast Cancer Res Treat (2009) 1.11
Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr (2009) 1.11
A genome-wide association study of breast cancer in women of African ancestry. Hum Genet (2012) 1.11
Obesity and survival among black women and white women 35 to 64 years of age at diagnosis with invasive breast cancer. J Clin Oncol (2011) 1.10
A pilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. J Natl Med Assoc (2009) 1.09
Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int J Cancer (2007) 1.09
Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation. Clin Transplant (2010) 1.08
Retracted Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer (2006) 1.05
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia (2004) 1.05
Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer (2007) 1.04
Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiol (2013) 1.03
Alcohol exposure and breast cancer: results of the women's contraceptive and reproductive experiences study. Cancer Epidemiol Biomarkers Prev (2004) 1.02
Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev (2013) 1.01
Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative Observational Study. Am J Epidemiol (2011) 1.01
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy. Asia Pac J Clin Oncol (2010) 1.00
Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer (2010) 1.00
Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev (2009) 0.99
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial. Nutr Cancer (2011) 0.99
Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer. Am J Clin Oncol (2010) 0.98
Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells. Mol Carcinog (2002) 0.98
Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model. Radiat Res (2006) 0.98
Gene markers of cellular aging in human multipotent stromal cells in culture. Stem Cell Res Ther (2014) 0.97
Barriers and facilitators for consumer adherence to the dietary guidelines for Americans: the HEALTH study. J Acad Nutr Diet (2013) 0.97
Phase I clinical trial of BMS-247550, a derivative of epothilone B, using accelerated titration 2B design. Clin Cancer Res (2005) 0.97
Zinc in cancer prevention. Nutr Cancer (2009) 0.97
Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancer. Clin Cancer Res (2008) 0.96
Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. J Am Diet Assoc (2003) 0.96
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med (2013) 0.96